Latest Stock Tips and Market Ideas- CBIS Top 10 Reasons to Buy

Recommended Stock Newsletters
#1. PennyStockWarfare
#2. Nova Stocks
#3. Penny Stock Finder

brassfinancial Newsletter

CBIS Top 10 Reasons to Buy ———————————————————— ** ———————————————————— **

———————————————————— ** Latest Stock Tips and Market Ideas CBIS Top 10 Reasons to Buy ———————————————————— Unlike your typical stock tips newsletter, we strive to bring you fresh plays that will bring you good returns Cannabis Science Inc Symbol: CBIS Top 10 Reasons to Buy CBIS 1. Major bounce alert issued for CBIS. Last bounce from these levels saw CBIS trading over $0.10, could it happen again Full size chart: 2. Cannabis Science Appoints Dr. Roscoe M. Moore Jr., US Assistant Surgeon General (retired) for a Second Term on the Scientific Advisory Board as Special Senior Advisor to the Company 3. Major exposure on CFO Journal: CFO Journal, part of the Wall Street Journal, addresses business challenges of cannabis industry in the article “Pot Industry Puts on a Tie” referencing Cannabis Science, Inc. (CBIS) Chief Financial Officer, Robert Kane 4. CBIS Prepares for New York State as it becomes the 23rd state to authorize Medical Marijuana use 5. Cannabis Science, Inc. (CBIS) Reports Strongest Financial Position in its History, Citing Filings & Financial Statements as the Company Moves Forward with Multiple Cannabis Drug Development Programs 6. Cannabis Science Inc. Moves Forward with MEDIWIET Preparing Observational Study in the Netherlands 7. Major growth is expected in the Medical Marijuana industry over the next year as additional states approve/expand MMJ usage.

8. CBIS Reports on CBS News; Historic Marijuana Vote from United States House of Representatives Creates Serious Confidence as Marijuana Wins U.S. House Vote for First Time in History 9. Shares Outstanding 844,323,906 a/o Jun 02, 2014 10. OTC QB The Company Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers and neurological conditions. Brought to you by: Blue Horseshoe Alerts ( Sign up for our free newsletter Friend on Facebook ( Follow on Twitter ( Forward to a Friend ( ** ———————————————————— ============================================================

** follow on Twitter ( | ** friend on Facebook ( | ** forward to a friend ( Copyright © 2014, All rights reserved.

You are receiving this email because you opted in at our website.

Our mailing address is: 14 Wall Street 20th Floor New York, NY 10005 USA Email Marketing Powered by MailChimp **

This entry was posted in Stock Newsletters and tagged . Bookmark the permalink.

Comments are closed.